Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas [Yahoo! Finance]
Iovance Biotherapeutics, Inc. (IOVA)
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
iovance.com
Company Research
Source: Yahoo! Finance
On February 24, Iovance Biotherapeutics announced positive early data from a pilot clinical trial evaluating its lifileucel TIL cell therapy in patients with advanced soft tissue sarcomas. The study focused on individuals with metastatic or unresectable undifferentiated pleomorphic sarcoma/UPS and dedifferentiated liposarcoma/DDLPS who had failed at least one prior systemic treatment. Among the first six evaluable patients, the therapy demonstrated a 50% objective response rate, with patients experiencing deep responses that improved over time despite a high baseline disease burden and multiple prior lines of therapy. Iovance Biotherapeutics Inc. (NASDAQ:IOVA) highlighted a significant unmet medical need for these aggressive cancers, which affect over 8,000 patients annually across the US and Europe. Current second-line treatment options typically yield response rates of less than 5%, with median overall survival often falling under one year. Iovance Biotherapeutics (IOVA) Announc
Show less
Read more
Impact Snapshot
Event Time:
IOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IOVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IOVA alerts
High impacting Iovance Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
IOVA
News
- Iovance Sarcoma Trial Data Puts TIL Platform And Stock In Focus [Yahoo! Finance]Yahoo! Finance
- Iovance (IOVA) Soars 33%, Hits All-Time High [Yahoo! Finance]Yahoo! Finance
- Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target [Yahoo! Finance]Yahoo! Finance
- UBS Raises PT on Iovance Biotherapeutics (IOVA) [Yahoo! Finance]Yahoo! Finance
- Iovance Biotherapeutics: The High-Risk Cancer Stock I Think Could Change a Portfolio by 2036 [Yahoo! Finance]Yahoo! Finance
IOVA
Earnings
- 2/24/26 - Beat
IOVA
Sec Filings
- 3/11/26 - Form 4
- 3/11/26 - Form 4
- 3/11/26 - Form 4
- IOVA's page on the SEC website